IL-6 and its downstream effector signal transducer and activator of transcription 3 (STAT3) are known to regulate apoptosis, angiogenesis, proliferation and differentiation, making them promising therapeutic targets in PCa [11]. The gene discussed is IL6; the disease is posterior cortical atrophy.